Only 10% of that is eligible to use Tali Health. So 28,000 x $300 = $8,400,000
Being a SaaS business with very low cost and highly scalable, I expect cost to be very low. Let's assume 25% is cost, we get roughly $6.3m. At PE of 30, we should get market cap of $180m (rounded down). At current market cap of around $55m, the share price can easily triple from here. But it will need another one or two substantial announcement. But that should all come to pass. Especially if an international deal is done.
At current price, this is such a compelling BUY
DYOR.
